dihexa fda approval status clinical trial dihexa human trials 2026 SCOPE 2026, Simplified Patient Recruitment Management, AI Powered Clinical Trial Finders FDA Peptide Reclassification 2026 |

The reduced levels of these two neurotransmitter metabolites, combined with other potential biomarkers, might be used to predict disease severity and movement disability in MS, even though the mechanisms through which these monoamine metabolites reversely regulate the progression of MS and the activities of neurotransmitters remain unclear

Psoriasis and obesity/metabolic syndrome Adipose tissue is known as the most important source of IL-6 in body

Cognitive function and mental clarity

As we age (and even due to stress, lifestyle, and environmental factors), the body experiences: Declining NAD+ levels leading to low energy and brain fog Slower cellular repair causing prolonged recovery and inflammation Reduced collagen production contributing to aging skin and tissue breakdown This is why you may notice: Chronic fatigue or burnout Slower workout recovery Joint discomfort or inflammation Dull skin, fine lines, or thinning hair This isnt just agingits cellular inefficiency